JOURNAVX — Product revenues, net
Vertex Pharmaceuticals JOURNAVX — Product revenues, net increased by 8.6% to $29M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2130.8%, from $1.3M to $29M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful market adoption, effective commercialization, and growing patient demand for the therapy, while a decrease may signal competitive pressure, market saturation, or challenges in patient access.
Detailed definition
This metric represents the total net sales generated from the JOURNAVX product line after accounting for returns, rebate...
Peer comparison
Comparable to product-specific net revenue lines reported by other biotechnology and pharmaceutical companies for their key commercialized assets.
vrtx_segment_journavx_product_revenues_netHistorical Data
| Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $0 | $0 | $1.3M | $12M | $19.6M | $26.7M | $29M |
| QoQ Change | — | — | — | — | — | +823.1% | +63.3% | +36.2% | +8.6% |
| YoY Change | — | — | — | — | — | — | — | — | >999% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's journavx — product revenues, net?
- Vertex Pharmaceuticals (VRTX) reported journavx — product revenues, net of $29M in Q1 2026.
- How has Vertex Pharmaceuticals's journavx — product revenues, net changed year-over-year?
- Vertex Pharmaceuticals's journavx — product revenues, net increased by 2130.8% year-over-year, from $1.3M to $29M.
- What does journavx — product revenues, net mean?
- The total net sales revenue generated specifically from the JOURNAVX product.